
About DXBIDT
DXBIDT is a Healthcare company based in Bengaluru (India) founded in 2021 by Umesh T G and Vikrama N Prabhu. Molecular biology enzymes and consumables are supplied by DXBIDT. Its website dxbidt.com draws about 13 thousand monthly visits. Its Indian entity Rubizon Private Limited reported revenue of ₹1.39 Cr. DXBIDT offers products and services including POLARIS SYBR®, VEGA® OneStep, and Taq DNA Polymerase. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Genomics.
Company details
DXBIDT was founded in 2021 and is based in Bengaluru, India. Operations focus on the molecular biology sector, where enzymes and consumables such as Taq DNA Polymerases, DNA Ladders, dNTPs, and Mastermixes are provided. Kits for PCR amplification, cDNA synthesis, and RNA analysis are also offered to support research and laboratory applications in the region.
- Headquarters Bengaluru, India
- Founders Umesh T G, Vikrama N Prabhu
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website dxbidt.com
- Social LinkedIn X Facebook Instagram
- Legal Name Rubizon Private Limited
- Date of Incorporation 11 Apr, 2017
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.39 Cr
FY 2025 · +119% YoY
- Net Profit₹19.4 Lakh
FY 2025 · 14% margin
- EBITDA₹24.6 Lakh
FY 2025 · 18% margin
Associated legal entities of DXBIDT
DXBIDT operates through Rubizon Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rubizon Private Limited CIN U24110KA2017PTC102177 | Active | 11 Apr 2017 | Bangalore, Karnataka | ₹1.4 Cr | 2 | View details |
Products & Services of DXBIDT
DXBIDT offers a comprehensive portfolio of products and services, including POLARIS SYBR®, VEGA® OneStep, and Taq DNA Polymerase.
Mastermix for accurate qPCR in molecular biology research applications.
Kit for integrated cDNA synthesis and amplification in lab settings.
Enzyme for reliable PCR reactions in genetic research.
Board of directors of Rubizon Private Limited (DXBIDT)
Rubizon Private Limited is the primary company behind DXBIDT. The board of Rubizon Private Limited currently have 2 directors; the longest-serving is Vikrama Narasimha Prabhu, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikrama Narasimha Prabhu DIN 08198554 | Director | 11 Aug 2018 | 8 yrs 3 mo | Rubizon Private Limited |
| Umesh Thippagondanahalli Ganeshappa DIN 08198565 | Director | 11 Aug 2018 | 8 yrs 3 mo | Rubizon Private Limited |
People of DXBIDT
2 people are tracked at DXBIDT (2 in leadership).
| Name | Role | Group |
|---|---|---|
Umesh T G | Co-Founder | Leadership |
| Co-Founder | Leadership |
Complete people profiles for DXBIDT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of DXBIDT
Figures of Rubizon Private Limited, the primary company behind DXBIDT, for FY 2025. Revenue was ₹1.39 Cr (+119% year on year). Net profit was ₹19.4 Lakh (14% margin). EBITDA was ₹24.6 Lakh (18% margin). Revenue has grown at a compounded annual rate of +105% over three years and +46% over five years.
- ₹1.39 CrRevenue · FY 2025 · +119% YoY
- ₹19.4 LakhNet profit · 14% margin
- ₹24.6 LakhEBITDA · 18% margin
- ₹1 LakhPaid-up capital
- +105%Revenue CAGR, 3 years
- +46%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rubizon Private Limited are on its company page.
Detailed financial statements for DXBIDT
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of DXBIDT
The website of DXBIDT (dxbidt.com) receives about 12.6K visits a month.
- Monthly visits12.6K
▼ 30.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DXBIDT
DXBIDT was founded in 2021.
DXBIDT is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
The primary company behind DXBIDT, Rubizon Private Limited, reported revenue of ₹1.39 Cr for FY 2025, up 119% year on year.
DXBIDT was founded in 2021 and is based in Bengaluru, India. Operations focus on the molecular biology sector, where enzymes and consumables such as Taq DNA Polymerases, DNA Ladders, dNTPs, and Mastermixes are provided. Kits for PCR amplification, cDNA synthesis, and RNA analysis are also offered to support research and laboratory applications in the region.
DXBIDT offers POLARIS SYBR®, VEGA® OneStep, and Taq DNA Polymerase.
DXBIDT operates through Rubizon Private Limited.
The legal entities of DXBIDT currently have 2 directors, including Vikrama Narasimha Prabhu, Umesh Thippagondanahalli Ganeshappa.